Skip to main
INMD
INMD logo

Inmode Ltd (INMD) Stock Forecast & Price Target

Inmode Ltd (INMD) Analyst Ratings

Based on 4 analyst ratings
Hold
Strong Buy 0%
Buy 25%
Hold 75%
Sell 0%
Strong Sell 0%

Bulls say

InMode Ltd demonstrated strong operational performance in the second quarter of 2025, selling 971 systems and achieving a global installed base increase of 3.4% to approximately 28,855 units, including 12,347 units in the United States. The company also reported an operating margin of 27.5%, surpassing previous estimates and reflecting a year-over-year increase of 40 basis points. Additionally, InMode's domestic sales reached $49.7 million, marking a significant improvement with a 9% growth compared to a decline of 7% in the prior quarter, underscoring the robust demand in the expanding aesthetic market.

Bears say

InMode Ltd is facing a negative outlook due to anticipated contraction in its gross margins, despite currently holding some of the highest margins in the med tech sector. Additionally, its earnings per share (EPS) growth is projected to lag behind revenue growth, indicating potential inefficiencies in translating revenue gains into profit. Furthermore, the company's revenue compound annual growth rate (CAGR) is expected to be less than 5% over the coming years as a result of weaker performance from existing products and slower adoption of new technologies.

Inmode Ltd (INMD) has been analyzed by 4 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 25% recommend Buy, 75% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Inmode Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Inmode Ltd (INMD) Forecast

Analysts have given Inmode Ltd (INMD) a Hold based on their latest research and market trends.

According to 4 analysts, Inmode Ltd (INMD) has a Hold consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Inmode Ltd (INMD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.